Project Grant R01AI167750
Award Date
2/1/22
Completion Date
1/31/27
Dollars Obligated
$814K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21205, USA
Similar Awards
This federal Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research), is supporting a $2,817,044 research program on "Systems Genetics of Tuberculosis" over 5 years. The project aims to use a mouse model system and human clinical samples to identify biological pathways influencing tuberculosis infection outcomes. Key activities include:
Leveraging genetic diversity in mouse and bacterial...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a 5-year, $127,980 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Johns Hopkins University. The award aims to integrate genomic and spatial data to improve the targeting of community-based tuberculosis (TB) screening and prevention interventions in high-burden settings. Key research objectives include refining subnational TB prevalence estimates, using genomic data to...
This $899,894 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to investigate the early immune cell interactions and signaling pathways that influence the progression of tuberculosis (TB) in co-infection with HIV. The prime recipient, Washington University, is collaborating with Massachusetts General Hospital and the University of Pittsburgh to define how type I interferon (IFN) and...
This $1,011,348 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to understand how the first interactions of Mycobacterium tuberculosis (M.TB) with the human alveolar environment, particularly alveolar lining fluid (ALF) and alveolar cells, are impacted by HIV infection. The research aims to determine how M.TB exposure to ALF from people living with HIV leads to...
This $1,297,775 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) supports research to investigate the role of sirtuins in regulating interactions between tuberculosis (TB) and HIV infections in macrophages. The primary awardee, The Methodist Hospital Research Institute, aims to:
Analyze the impact of early TB and HIV infection on sirtuin gene and protein induction in macrophages, and develop an...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $246,000 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the University of Chicago to investigate the role of lung repair and regeneration pathways in tuberculosis (TB). The research project aims to determine the functional role of the bone morphogenetic protein (BMP) signaling pathway in controlling Mycobacterium tuberculosis (MTB) infection and preventing TB reactivation. Additionally, the...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) has awarded a 5-year, $1,233,520 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Johns Hopkins University. The grant, titled "CHIPP-PREP: CABOTEGRAVIR-HORMONE INTERROGATION OF PHARMACOKINETICS/PHARMACODYNAMICS FOR HIV PREVENTION IN CISGENDER AND TRANSGENDER PERSONS", aims to characterize the relationship between gender-affirming hormone therapy and long-acting...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) will support a comprehensive study to characterize the immune response to tuberculosis (TB) across different disease states. The $517,185 award to the University of California, Davis, with a sub-award to Stellenbosch University in South Africa, will fund the integration of single-cell multi-omics profiling and ancestry-adjusted expression...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $149,528 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Johns Hopkins University to conduct research into sex differences in vaccine-induced immunity. The project aims to investigate the potential role of mTOR activation and metabolic signaling in B cells as a mechanism governing sex-specific differences in humoral immune responses following influenza vaccination. The...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) provides $743,698 to Trustees of Boston University, doing business as Boston University Medical Campus, to conduct research on the relationship between interleukin-6 (IL-6) signaling, lung injury, and post-tuberculosis (TB) lung disease in patients with and without HIV.
The research aims to extensively characterize and compare lung injury at TB...